X0202 4 2005-10-14 0 0001138812 COTHERIX INC CTRX 0001257444 ALTA BIOPHARMA PARTNERS III LP ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 0001198321 CHAMPSI FARAH ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 0001198323 DELEAGE JEAN ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 0001106287 GRUENER GARRETT ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 0001198328 MARDUEL ALIX ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 0001198330 NOHRA GUY P ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 0001276361 ALTA PARTNERS II INC ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 0001211840 HURWITZ EDWARD ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 0001198332 PENHOET EDWARD ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 0001341610 Alta Partners III, Inc. ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94111 0 0 1 0 Common Stock 2005-10-14 4 S 0 152900 13.00 D 869164 I See footnotes Common Stock 2005-10-14 4 S 0 10268 13.00 D 58370 I See footnotes Common Stock 2005-10-14 4 S 0 3769 13.00 D 21415 I See footnotes Common Stock 2301037 I See footnotes Common Stock 62226 I See footnotes Not applicable Alta BioPharma Partners III, L.P. sold 152,900 shares of Common Stock at the Issuer's Follow-on Public Offering at $13.00/sh for a total of $1,987,700.00. Daniel Janney, Director, is a managing director of Alta California Management Partners III, LLC ("ACMPIII") (which is the general partner ("gp") of Alta California Partners III, L.P. ("ACPIII") & a manager of Alta Embarcadero Partners III, LLC ("AEPIII"). As a managing director & manager of such funds, he may be deemed to share voting & investment powers over the shares held by ACPIII & AEPIII. He is a member of Alta BioPharma Management III, LLC ("ABPMIII") with no voting or investment powers over the shares held by Alta BioPharma Partners III, L.P. ("ABPIII"). He disclaims ownership of all such shares held by all the foregoing funds except to the extent of their proportionate pecuniary interests therein. Alta Partners II, Inc. & Alta Partners III, Inc. provide investment advisory services to several funds including ACPIII, AEPIII, ABPIII, Alta BioPharma Partners III GmbH & Co. Beteiligungs KG ("ABPIIIKG") & Alta Embarcadero BioPharma Partners III, LLC ("AEBPIII"). The managing directors ("md") of ABMPIII (which is the gp of ABPIII & ABPIIIKG) & managers of AEBPIII, exercise sole voting & investment powers with respect to the sh ("sh")owned by such funds. G Gruener, G Nohra & D Janney (collectively known as the "principals") are md of ACMPIII & managers of AEPIII. J Deleage, F Champsi, A Marduel, E Hurwitz & E Penhoet (collectively known as the "principals") are directors of ABMPIII (which is the gp of ABPIII & ABPIIIKG & managers of AEBPIII, The principals may be deemed to share voting & investment powers over the sh held by the funds. The principals disclaim beneficial ownership of all such sh held by the funds, except to the extent of their porportionate pecuniary interest therein. Alta BioPharma Partners III GmbH & Co. Beteiligungs KG sold 10,268 shares of Common Stock at the Issuer's Follow-on Public Offering at $13.00/sh for a total of $133,484.00. Alta Embarcadero BioParma Partners III, LLC sold 3,769 shares of Common Stock at the Issuer's Follow-on Public Offering for $13.00/sh for a total of $48,997.00. Alta California Partners III, L.P. holds 2,301,037 shares of Common Stock. Alta Embarcadero Partners III, LLC holds 62,226 shares of Common Stock. Cross-reference to Form 4 for Daniel Janney filed on 10/18/2005. Farah Champsi, Director 2005-10-18 Farah Champsi 2005-10-18 Jean Deleage 2005-10-18 Garrett Gruener 2005-10-18 Alix Marduel 2005-10-18 Guy Nohra 2005-10-18 Jean Deleage, President 2005-10-18 Edward Hurwitz 2005-10-18 Edward Penhoet 2005-10-18 Jean Deleage, President 2005-10-18